Contineum Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
CTNM
CUSIP
21217B100
Type
Equity
Class
CL A
Num filings
91
Total reported value, excl. options
$399 M
Manager Report Date Value ($000) Shares Option Type